Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001705112 | SCV000250386 | likely benign | not provided | 2019-04-18 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27724990) |
Invitae | RCV000227564 | SCV000287145 | benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000659663 | SCV000781506 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002453720 | SCV002614337 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-10-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002503765 | SCV002808536 | likely benign | Cardiac valvular dysplasia, X-linked; FG syndrome 2; Heterotopia, periventricular, X-linked dominant; Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked; Melnick-Needles syndrome; Oto-palato-digital syndrome, type I; Oto-palato-digital syndrome, type II; Terminal osseous dysplasia-pigmentary defects syndrome; Frontometaphyseal dysplasia 1 | 2022-03-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001705112 | SCV004010971 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | FLNA: PP2, BS2 |